/
/
/

CORONA Remedies Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,121.00
Volume (₹)9,401.00
High (₹)2,150.40
Upper Circuit2,553.30
Low (₹)2,090.80
Lower Circuit1,702.30
Prev Close2,127.80
52W High (₹)2,270.10
Price2,106.70
52W Low (₹)1,336.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)12992.50 Cr
Div. Yield (%)0.47
PE Ratio65.28
Debt to Equity0.19
Price to Book12.74
Book Value122.12
EPS (TTM)32.54
Face Value10.00
ROE (%)27.36

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
CORONANSE
LTP
1W Low
1W High
Market cap (₹)
1904.9-15.1 (-0.79%)
1896.80
1984.80
4,56,833Cr
9149-90 (-0.97%)
9087
9467
2,45,426Cr
4830.5-219.5 (-4.35%)
4823
5066
1,87,320Cr
1128.7-62.3 (-5.23%)
1125.10
1187
1,13,217Cr
1380.3-43.2 (-3.03%)
1376
1426.10
1,12,212Cr
1845.8-92.7 (-4.78%)
1811.70
1949
1,01,155Cr
2110.6-60.9 (-2.80%)
2107.20
2192
97,626Cr
2331.8-51.1 (-2.14%)
2327.30
2419.20
96,859Cr
1156.7-21.3 (-1.81%)
1154.40
1179.90
96,406Cr
1660.8+15.5 (0.94%)
1622.60
1717
93,614Cr
2106.7+27.2 (1.31%)
2020.20
2150.40
12,993Cr

Key Highlights of CORONA Remedies Ltd Balance Sheet

CORONA Remedies Ltd balance sheet discloses shareholders' funds of ₹61.16Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹61.16Cr, and the reserves and surplus of the company is ₹684.81Cr.

The company has its non-current liabilities with total liabilities of ₹1297.61Cr as of 2026-03-31.

The current liabilities are ₹454.53Cr as of 2026-03-31. At the same time, current assets are ₹441.67Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹25.4Cr and tangible assets of ₹553.97Cr, provided in the CORONA Remedies Ltd financial statements.